Clin2
NCT04650256Possibly a fitRecruiting

Chinese herbal add-on after breast surgery

Skin Toxicity

Part of Cancer, Skin clinical trials.

This trial looks at whether a Chinese herbal complementary treatment used alongside standard radiation after breast cancer surgery can improve health outcomes. It is for women newly diagnosed with certain stages of breast cancer who are planning chest-wall radiation.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
40 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are a woman, age 18 or older
  • You have been newly diagnosed with breast cancer
  • You have had a mastectomy (breast removal), with or without reconstruction
  • Your cancer is stage II to IIIb (not stage T4, and not spread to distant organs)
  • You plan to get radiation to the chest wall (possibly nearby lymph nodes) soon after surgery
  • You must be able to consent in English or Spanish and be willing to sign the study consent form

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06881550Enrolling by invitation
Herbal medicine study for women after breast cancer surgery

This trial tests whether a Chinese herbal medicine (Shenbailing granules) can help improve energy and blood health in women recovering from breast cancer surgery.

Shenyang, Chian/Liaoning
NCT05420467Recruiting· Phase 4
Trial of add-on breast cancer treatment after surgery

This Phase 4 study tests an additional (adjuvant) treatment for breast cancer after surgery and standard follow-up care. It may help lower the chance the cancer comes back, but you must match specific tumor and body-chemistry requirements to join.

Hangzhou, Zhejiang
NCT06914440Recruiting· Phase 2
Radiation and immunotherapy before surgery for HR+/HER2- breast cancer

This trial is testing a new treatment approach for patients with a certain type of breast cancer (HR+/HER2-). It combines radiation therapy with chemotherapy and an immunotherapy drug before the patient's main surgery, to see if it can shrink or eliminate the tumor more effectively.

Xi'an, Shannxi Province
NCT06671262Recruiting· Phase 2
Immunotherapy plus radiation before breast cancer surgery

This trial tests combining two treatments—an immunotherapy drug (Toripalimab) and radiation—before surgery for a certain type of breast cancer (HR+, HER2-negative) that has spread to lymph nodes. The goal is to see if this combination helps shrink the tumor more than standard therapy alone.

Hangzhou, Zhejiang
NCT05059379Recruiting· Phase 3
Different radiation fields after breast cancer surgery

This trial compares two ways of giving radiation to lymph node areas near the collarbone after surgery for invasive breast cancer. It aims to see which radiation approach works better and is safer for preventing cancer returning in these lymph nodes.

Shanghai, Shanghai Municipality
NCT04261244Recruiting· Phase 3
Neoadjuvant radiation study for one-sided breast cancer

This Phase 3 study tests a specific plan that combines chemotherapy (and sometimes targeted medicines) with radiation before surgery for one breast. It may help shrink breast cancer and improve treatment timing, based on how well tumors respond.

Ahaus

Hear when a new Skin Toxicity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.